952 related articles for article (PubMed ID: 33957219)
1. Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study.
Papachristofilou A; Finazzi T; Blum A; Zehnder T; Zellweger N; Lustenberger J; Bauer T; Dott C; Avcu Y; Kohler G; Zimmermann F; Pargger H; Siegemund M
Int J Radiat Oncol Biol Phys; 2021 May; ():. PubMed ID: 33957219
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study.
Papachristofilou A; Finazzi T; Blum A; Zehnder T; Zellweger N; Lustenberger J; Bauer T; Dott C; Avcu Y; Kohler G; Zimmermann F; Pargger H; Siegemund M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1274-1282. PubMed ID: 33677049
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
Saleh M; Sharma K; Shah J; Karsan F; Waweru A; Musumbi M; Shah R; Sayed S; Abayo I; Karimi N; Gondi S; Rupani S; Kirathe G; Amariati H
PLoS One; 2022; 17(7):e0270594. PubMed ID: 35776736
[TBL] [Abstract][Full Text] [Related]
5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
7. Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study.
Singh P; Mandal A; Singh D; Kumar S; Kumar A; Rakesh A; Ranjan R; Verma M; Rai DK; Bhushan D; Shankar A; Sinha A; Saini R; Saha A; Thovarayi A; Baral AK; Chauhan S; Kumar R; Kakoty P; Modak B; Ranjan A
Front Oncol; 2022; 12():822902. PubMed ID: 35425707
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
9. Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Shree Vaishnavi R
Radiother Oncol; 2021 Oct; 163():83-90. PubMed ID: 34391759
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
12. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
Hess CB; Nasti TH; Dhere VR; Kleber TJ; Switchenko JM; Buchwald ZS; Stokes WA; Weinberg BD; Rouphael N; Steinberg JP; Godette KD; Murphy DJ; Ahmed R; Curran WJ; Khan MK
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):867-879. PubMed ID: 33340603
[TBL] [Abstract][Full Text] [Related]
14. Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial).
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Govindaraj HS; Raguram SV
Radiother Oncol; 2022 Feb; 167():133-142. PubMed ID: 34958809
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
16. Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial.
Labro G; Tubach F; Belin L; Dubost JL; Osman D; Muller G; Quenot JP; Da Silva D; Zarka J; Turpin M; Mayaux J; Lamer C; Doyen D; Chevrel G; Plantefeve G; Demeret S; Piton G; Manzon C; Ochin E; Gaillard R; Dautzenberg B; Baldacini M; Lebbah S; Miyara M; Pineton de Chambrun M; Amoura Z; Combes A;
Intensive Care Med; 2022 Jul; 48(7):876-887. PubMed ID: 35676335
[TBL] [Abstract][Full Text] [Related]
17. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
20. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
